ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 128 filers reported holding ANIKA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $14,000 | +7.7% | 0 | -100.0% | 0.00% | – |
| Q2 2022 | $13,000 | -13.3% | 580 | 0.0% | 0.00% | – |
| Q1 2022 | $15,000 | -28.6% | 580 | 0.0% | 0.00% | – |
| Q4 2021 | $21,000 | -16.0% | 580 | 0.0% | 0.00% | – |
| Q3 2021 | $25,000 | 0.0% | 580 | 0.0% | 0.00% | – |
| Q2 2021 | $25,000 | -10.7% | 580 | -14.5% | 0.00% | – |
| Q1 2021 | $28,000 | -37.8% | 678 | -32.2% | 0.00% | – |
| Q4 2020 | $45,000 | +28.6% | 1,000 | 0.0% | 0.00% | – |
| Q3 2020 | $35,000 | -7.9% | 1,000 | 0.0% | 0.00% | – |
| Q2 2020 | $38,000 | +31.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2020 | $29,000 | -44.2% | 1,000 | 0.0% | 0.00% | – |
| Q4 2019 | $52,000 | -64.9% | 1,000 | -63.0% | 0.00% | – |
| Q3 2019 | $148,000 | -81.6% | 2,700 | -86.4% | 0.00% | – |
| Q2 2019 | $804,000 | +3920.0% | 19,800 | +3200.0% | 0.00% | – |
| Q4 2018 | $20,000 | -33.3% | 600 | -14.3% | 0.00% | – |
| Q3 2018 | $30,000 | -6.2% | 700 | -30.0% | 0.00% | – |
| Q2 2018 | $32,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 44,875 | $2,031,000 | 2.14% |
| Parian Global Management LP | 102,705 | $4,648,000 | 1.16% |
| CAPITAL MANAGEMENT CORP /VA | 93,035 | $4,211,000 | 1.15% |
| Avidity Partners Management LP | 731,000 | $33,085,000 | 1.07% |
| Sio Capital Management, LLC | 65,382 | $2,959,000 | 0.61% |
| DIKER MANAGEMENT LLC | 21,835 | $988,000 | 0.50% |
| Archon Capital Management LLC | 48,925 | $2,214,000 | 0.38% |
| Caption Management, LLC | 362,800 | $16,420,000 | 0.37% |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,546,260 | $69,984,000 | 0.20% |
| Boston Trust Walden Corp | 378,167 | $17,116,000 | 0.18% |